Dr. Jerry Mendell, Director of the Centers for Gene Therapy and Muscular Dystrophy at Nationwide Children's Hospital and principal investigator of the Phase IIb eteplirsen study, presented the full set of 48-week data from Sarepta at the World Muscle Society (WMS) Congress in Perth, Australia on Friday, October 13. This presentation includes greater detail around the full Phase IIb study results.
Additional data presented at WMS included:
We look forward to the Sarepta webinar on October 23, where your questions will be answered by the Sarepta team. Learn more about the upcoming webinar.
Learn more
© 2019 Created by PPMD.
Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service
You need to be a member of PPMD Community to add comments!
Join PPMD Community